Research › Fact Sheets › CI

CIGNA GROUP

LISTEDNYSE

SYMBOLCI

SIC6324

STATE OF INC.DE

FISCAL YEAR ENDSDecember 31

CIK1739940

HOSPITAL & MEDICAL SERVICE PLANS · LARGE ACCELERATED FILER · 10 FISCAL YEARS OF SEC XBRL DATA, 2016–2025

Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.

CAPITALIZATION 12/31/25

($ millions)	Amount	%
Total debt	31,463	43.0
Stockholders' equity	41,713	57.0
Total capitalization	73,176	100.0

264,240,486 shares outstanding at 24 July 2026 (cover page of the 10-Q filed 30 July 2026).

LONG-TERM DEBT 12/31/25

($ millions)	Amount
Long-term debt, noncurrent	30,871
Current maturities	592
Short-term borrowings / commercial paper	0

CAPITAL STOCK 12/31/25

Common shares authorized	600,000,000
Common shares issued	404,600,000
Treasury shares	141,136,000
Par or stated value per share ($)	0.01
Outstanding at 7/24/26	264,240,486

DIVIDENDS DECLARED/PAID

Fiscal year	Per share $	Payout %
2025	6.04	27.2
2024	5.60	46.2
2023	4.92	28.3
2022	4.48	20.9
2021	4.00	25.4

HISTORY AND BUSINESS

HISTORY: Incorporated in Delaware. Formerly known as Cigna Corp (to 9 February 2023); Halfmoon Parent, Inc. (to 20 December 2018).

BUSINESS: Classified by the SEC under Standard Industrial Classification 6324, Hospital & Medical Service Plans. Large accelerated filer. Principal executive office: 900 Cottage Grove Road, Bloomfield, CT 06002. Fiscal year ends December 31. For a description of the business, see Item 1 of the latest 10-K.

CONSOLIDATED INCOME ACCOUNT, YEARS ENDED

($ millions)	12/31/25	12/31/24	12/31/23
Premiums earned	40,261	45,996	44,237
Net investment income	1,046	973	1,166
Total revenues	274,900	247,121	195,265
Benefits, losses and expenses	265,700	237,704	186,729
Income before income taxes	7,781	5,269	5,513
Income taxes	1,493	1,491	141
Net income	5,957	3,434	5,164
Earned per share, diluted ($)	22.18	12.12	17.39
Dividends per share ($)	6.04	5.60	4.92

CONSOLIDATED BALANCE SHEET

($ millions)	12/31/25	12/31/24
Total investments	19,527	15,793
Cash and equivalents	7,676	7,550
Total assets	157,919	155,881
Total liabilities	116,045	114,638
Stockholders' equity	41,713	41,033

TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)

Fiscal year ended	Revenues	Oper. income	Net income	Net margin %	EPS diluted $	Div. per share $	Oper. cash flow	Total assets	Total liabilities	Total debt	Deposits	Stockholders' equity	ROE %	Debt / equity
12/31/25	274,900	9,200	5,957	2.2	22.18	6.04	9,601	157,919	116,045	31,463	–	41,713	14.3	0.75
12/31/24	247,121	9,417	3,434	1.4	12.12	5.60	10,363	155,881	114,638	32,852	–	41,033	8.4	0.80
12/31/23	195,265	8,536	5,164	2.6	17.39	4.92	11,813	152,761	106,410	32,167	–	46,223	11.2	0.70
12/31/22	180,518	8,450	6,704	3.7	21.41	4.48	8,656	143,885	99,131	31,093	–	44,675	15.0	0.70
12/31/21	174,069	7,941	5,370	3.1	15.75	4.00	7,191	154,889	107,705	35,697	–	47,112	11.4	0.76
12/31/20	160,401	8,153	8,458	5.3	22.96	0.04	10,350	155,451	105,065	33,949	–	50,321	16.8	0.67
12/31/19	153,566	8,077	5,104	3.3	13.44	0.04	9,485	155,774	110,395	38,351	–	45,338	11.3	0.85
12/31/18	48,650	4,160	2,637	5.4	10.54	0.04	3,770	153,226	112,154	41,023	–	41,028	6.4	1.00
12/31/17	41,806	3,942	2,237	5.4	8.77	0.04	4,086	61,759	47,999	5,430	–	13,711	16.3	0.40
12/31/16	39,838	3,088	1,867	4.7	7.19	–	4,026	–	–	–	–	13,703	13.6	–

Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; capital expenditure and free cash flow are not shown for banks and insurers, where they are not meaningful; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.

REGISTRANT:

Cigna Group
CIK 1739940 · EIN 82-4991898

PRINCIPAL OFFICE:

900 Cottage Grove Road, Bloomfield, CT 06002
Tel.: 8602266000

INCORPORATED:

Delaware

INDUSTRY (SEC SIC CODE):

6324 · Hospital & Medical Service Plans

FILER STATUS:

Large accelerated filer

LATEST ANNUAL REPORT:

10-K for period ended 12/31/25, filed 26 February 2026

FORMER NAMES:

Cigna Corp; Halfmoon Parent, Inc.

RECENT FILINGS (ANNUAL REPORT REFERENCES BELOW):

10/9/26	8-K	period 10/6/26
9/30/26	8-K	period 9/30/26
7/30/26	10-Q	period 6/30/26
7/30/26	8-K	period 7/30/26
5/13/26	8-K	period 5/13/26
4/30/26	10-Q	period 3/31/26
4/30/26	8-K	period 4/30/26
4/27/26	8-K	period 4/22/26

Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2025 (filed 2/26/26) · 10-K FY2024 (filed 2/27/25) · 10-K FY2023 (filed 2/29/24) · 10-K FY2022 (filed 2/23/23) · 10-K FY2021 (filed 2/24/22) · 10-K FY2020 (filed 2/25/21) · 10-K FY2019 (filed 2/27/20) · 10-K FY2018 (filed 2/28/19). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.